Olema Pharmaceuticals
OLMA
185 hedge funds and large institutions have $1.28B invested in Olema Pharmaceuticals in 2026 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 74 increasing their positions, 60 reducing their positions, and 33 closing their positions.
42% more call options, than puts
Call options by funds: $6.86M | Put options by funds: $4.84M
23% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 60
0.26% more ownership
Funds ownership: 116.42% → 116.69% (+0.26%)
5% less funds holding
Funds holding: 195 → 185 (-10)
16% less capital invested
Capital invested by funds: $1.51B → $1.28B (-$238M)
21% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 33
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$23.5M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$20.1M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$15.1M |
| 4 |
Vanguard Portfolio Management
Malvern,
Pennsylvania
|
+$14.3M |
| 5 |
BlackRock
New York
|
+$14.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$38.8M |
| 2 |
Jennison Associates
New York
|
-$27.2M |
| 3 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$23.9M |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$23.4M |
| 5 |
FTM
First Turn Management
Del Mar,
California
|
-$11.5M |
OLMA Hedge Fund Activity: Q2 2026 in Review
185 of the 8,317 institutional investors tracked by Wall St. Rank reported a position in Olema Pharmaceuticals (OLMA) for Q2 2026, worth a combined $1.28B — down 16% from $1.51B a quarter earlier.
Sellers outnumbered buyers: 33 funds closed out of OLMA and 26 opened new positions — a net loss of 7 holders — while 60 trimmed existing stakes and 74 added.
The largest buyer was Fidelity Investments, adding an estimated $23.5M. The largest seller was RA Capital Management, exiting entirely with an estimated $38.8M sold.
- 185 institutional investors held Olema Pharmaceuticals (OLMA) as of Q2 2026, down from 195 in Q1 2026.
- Funds reported $1.28B of Olema Pharmaceuticals stock for Q2 2026, down 16% quarter-over-quarter.
- 26 funds opened new Olema Pharmaceuticals positions in Q2 2026 and 33 closed out, a net change of -7 holders.
- The largest Olema Pharmaceuticals buyer in Q2 2026 was Fidelity Investments, an estimated $23.5M added.
- The largest Olema Pharmaceuticals seller in Q2 2026 was RA Capital Management, an estimated $38.8M sold.
Based on aggregated 13F filings for Q2 2026.